Coronavirus city Manchester hospital covid-19 NHS patient Coronavirus city Manchester

Manchester doctors are leading the way with drug that 'reduces number of deaths among COVID-19 patients'

Manchester University NHS Foundation Trust (MFT) hospitals, including the Manchester Royal Infirmary(MRI), Wythenshawe Hospital and North Manchester General.

Dr Felton said: "Dexamethasone, which is a type of steroid used in a range of conditions – typically to reduce inflammation – is the first drug to improve survival rates in hospitalised coronavirus patients, which truly is a breakthrough."The short timeframe between our first MFT participant being recruited to the RECOVERY trial in March, to our first COVID-19 patient receiving dexamethasone as a standard NHS treatment in June, is an incredible turnaround."This could not have happened without patients consenting to take part in research – which is now directly benefitting all patients.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News